Al-Azhar University at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
Al-Azhar University brings 2 presentations to IDWeek 2026 in Washington. Its program centres on pooled and national analyses of tuberculous meningitis treatment and of deaths in hospital among MRSA patients. One review asks whether higher doses of rifampicin improve survival in tuberculous meningitis.
| Organization | IDWeek 2026 Attendance |
|---|---|
Al-Azhar University Cairo, Egypt | |
Poster Fri Oct 23 12:15pm–1:30pm Does Dose Escalation of Rifampicin Improve Survival in Tuberculous Meningitis? An Updated Systematic Review and Meta-Analysis Poster Sat Oct 24 12:15pm–1:30pm Racial and Ethnic Disparities in In-Hospital Mortality Among MRSA-Coded Hospitalizations in the United States, 2016-2022: A Nationwide Fairlie Decomposition Analysis |
Instantly find 20 buyers from Al-Azhar University
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction